← Evidence map

ReviewPharmacoEconomics2001

Augmenting reference pricing of pharmaceuticals in New Zealand with strategic cross-product agreements.

A WoodfieldPubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 11383753